Abstract: A pharmaceutical composition comprising A) one or more ASO or a pharmaceutically acceptable salt thereof; B) one or more permeation enhancer; C) one or more optional pharmaceutically acceptable excipient; and D) one or more optional coating. Said composition for use in the treatment, prevention, or amelioration of a disease associated with PCSK9 or PNPLA3 in a subject.

Abstract: The present disclosure relates to a process to reduce total acid number (TAN) of a heat transfer fluid. The process comprises contacting the heat transfer fluid with an adsorbent composition at a temperature in the range of 50° C. to 350° C. and a pressure in the range of 1 bar to 10 bar to obtain a treated heat transfer fluid having total acid number (TAN) in the range of 0.003 to 0.03 and pH in the range of 6 to 7.5, wherein the adsorbent composition is provided in a fixed bed and the heat transfer fluid is passed through the fixed bed comprising the adsorbent composition at a liquid hourly space velocity (LHSV) in the range of 0.5 per hour to 10 per hour.